STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about MAR
Insiders, 180 days
-$6.5M net sold
5 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-09-23
Planned sales (Form 144), 90 days
$3.7M
3 notices
Marriott International insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, MARRIOTT INTERNATIONAL INC /MD/ insiders sold a net $6.5M of stock across 116 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Nobody has filed for crossing 5%. That is a fact, not missing data.
MAR planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Harrison Deborah Marriott
Filed 2026-09-25
$1.2M
MARRIOTT J W JR
Filed 2026-09-25
$1.2M
Marriott David S
Filed 2026-09-25
$1.2M
Executive pay vs shareholder return · Mr Capuano
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2022
$18.7M
$18.0M
$6.3M
-1%
-33%
2020
$8.9M
$5.5M
$4.2M
-13%
-26%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $6.5M sold by insiders over 180 days, $3.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$26.9B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MAR
FY Dec 2025
$26.2B
FY Dec 2024
$25.1B
FY Dec 2023
$23.7B
FY Dec 2022
$20.8B
FY Dec 2021
$13.9B
Jun 2026
$7.1B
Mar 2026
$6.7B
Dec 2025
$6.7B
Sep 2025
$6.5B
Jun 2025
$6.7B
Mar 2025
$6.3B
Dec 2024
$6.4B
Sep 2024
$6.3B
At each fiscal year end
Single quarter
Net margin, TTM
+9.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MAR
FY Dec 2025
+9.9%
FY Dec 2024
+9.5%
FY Dec 2023
+13.0%
FY Dec 2022
+11.4%
FY Dec 2021
+7.9%
Jun 2026
+10.8%
Mar 2026
+9.7%
Dec 2025
+6.7%
Sep 2025
+11.2%
Jun 2025
+11.3%
Mar 2025
+10.6%
Dec 2024
+7.1%
Sep 2024
+9.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
$3.1B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MAR
FY Dec 2025
$2.6B
FY Dec 2024
$2.0B
FY Dec 2023
$2.7B
FY Dec 2022
$2.0B
FY Dec 2021
$994.0M
Jun 2026
$796.0M
Mar 2026
$728.0M
Dec 2025
$657.0M
Sep 2025
$951.0M
Jun 2025
$488.0M
Mar 2025
$512.0M
Dec 2024
-$24.0M
Sep 2024
$706.0M
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity MAR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.16x
FY Dec 2021
0.10x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
162.09x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt MAR
FY Dec 2025
139.65x
FY Dec 2024
49.98x
FY Dec 2023
56.61x
FY Dec 2022
25.68x
FY Dec 2021
8.72x
Jun 2026
162.09x
Mar 2026
148.83x
Dec 2025
139.65x
Sep 2025
117.43x
Jun 2025
108.17x
Mar 2025
113.78x
Dec 2024
49.98x
Sep 2024
56.82x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity MAR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
+237.9%
FY Dec 2021
+119.2%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+9.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MAR
FY Dec 2025
+9.7%
FY Dec 2024
+9.2%
FY Dec 2023
+12.2%
FY Dec 2022
+9.4%
FY Dec 2021
+4.4%
Jun 2026
+9.3%
Mar 2026
+9.5%
Dec 2025
+9.7%
Sep 2025
+9.7%
Jun 2025
+9.3%
Mar 2025
+9.4%
Dec 2024
+9.2%
Sep 2024
+10.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
invested capital is zero or negative
Return on invested capital MAR
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
+1,971%
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+21.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed MAR
FY Dec 2025
+22.6%
FY Dec 2024
+21.3%
FY Dec 2023
+21.8%
FY Dec 2022
+18.9%
FY Dec 2021
+9.2%
Jun 2026
+21.6%
Mar 2026
+22.6%
Dec 2025
+22.6%
Sep 2025
+22.4%
Jun 2025
+21.2%
Mar 2025
+21.4%
Dec 2024
+21.3%
Sep 2024
+21.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
40.40x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MAR
FY Dec 2025
32.62x
FY Dec 2024
33.49x
FY Dec 2023
22.15x
FY Dec 2022
20.54x
FY Dec 2021
49.47x
Jun 2026
38.32x
Mar 2026
34.25x
Dec 2025
32.62x
Sep 2025
27.47x
Jun 2025
30.77x
Mar 2025
27.10x
Dec 2024
33.49x
Sep 2024
26.03x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$101.4B
market value at close 2026-10-23 on 2026-07-27 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value MAR
FY Dec 2025
$82.9B
FY Dec 2024
$77.2B
FY Dec 2023
$65.9B
FY Dec 2022
$46.7B
FY Dec 2021
$52.6B
Jun 2026
$97.3B
Mar 2026
$86.2B
Dec 2025
$82.9B
Sep 2025
$70.0B
Jun 2025
$74.2B
Mar 2025
$65.2B
Dec 2024
$77.2B
Sep 2024
$69.6B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.1%
TTM free cash flow over market value at close 2026-10-23
FCF yield MAR
FY Dec 2025
+3.1%
FY Dec 2024
+2.6%
FY Dec 2023
+4.1%
FY Dec 2022
+4.3%
FY Dec 2021
+1.8%
Jun 2026
+3.2%
Mar 2026
+3.3%
Dec 2025
+3.1%
Sep 2025
+2.7%
Jun 2025
+2.2%
Mar 2025
+2.8%
Dec 2024
+2.6%
Sep 2024
+3.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
4.54x
P/E over trailing EPS growth of 9%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MAR
FY Dec 2025
2.30x
FY Dec 2024
n/a
FY Dec 2023
0.55x
FY Dec 2022
0.18x
FY Dec 2021
n/a
Jun 2026
4.31x
Mar 2026
3.96x
Dec 2025
2.30x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
20.46x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MAR ranks highest on financial health (99th percentile) and profitability (87th), and lowest on insider conviction (14th), among Restaurants & Leisure peers.
Profitability
87
Inputs
Return on equityaverage equity is zero or negative
Return on assets+9.3% · 83 pct, sector of 120
Return on invested capitalinvested capital is zero or negative
Return on capital employed+21.6% · 90 pct, sector of 104
Financial health
100
Inputs
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt162.09x · 100 pct, sector of 105
Growth
49
Inputs
Revenue growth, YoY+4.3% · 49 pct, sector of 143
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
14
Inputs
Net Form 4 buying (codes P and S), 180d-$6.5M · 28 pct, sector of 77
Insider buyers, 180d0 · 0 pct, sector of 77
Institutional and government
85
Inputs
Funds adding, latest quarterfewer than five funds report holding it
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$2.5M · 85 pct, universe of 1,063
Risk and compliance
38
Inputs
Short interest, % of float+3.0% · 64 pct, sector of 150
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.04 per $1B · 15 pct, universe of 1,048
New text in Risk Factors, latest 10-K+13.9% · 35 pct, sector of 100
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MAR filings, in plain words
Are Marriott International insiders buying or selling MAR?
In the 180 days to 2026-10-27, Marriott International insiders were net sellers, a net $6.5M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded MAR?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Valerie Hoyle dated 2025-09-23.
Are there planned insider sales of MAR?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $3.7M of stock; the latest, by Harrison Deborah Marriott, was filed 2026-09-25.
Read the full summary
In the 180 days to 2026-10-27, Marriott International insiders were net sellers of MAR, a net $6.5M across purchases and sales reported on Form 4 by 5 sellers. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in MAR, none in the last year; the latest on record is a sale by Valerie Hoyle dated 2025-09-23. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $3.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.